Mishcon de Reya advises Quotient on the sale of HFL Sport Science Limited

Mishcon de Reya advised Quotient Bioresearch Group Limited on the sale of HFL Sport Science Limited (HFL) to LGC Limited. HFL operates drug surveillance services in respect of sport and provides supplements, nutrition, fitness and health testing services. It is the world’s largest independent provider of drug surveillance, doping control and research activities to human and equine sports.

The Mishcon de Reya team was led by corporate partner Richard Tyler and corporate assistant Ben Annable, and included assistants Neville Moore (corporate), Sarah Spurling (banking) and tax partner Jonathan Legg.

Richard Tyler commented: "We were pleased to bring this transaction to its close in time for the Christmas break for all parties concerned, having effectively had a four week transaction process."

Quotient’s Chief Financial Officer Gordon Cameron said: “The team at Mishcon provide us with top class support and ensured that this deal was completed efficiently within the shortest possible timeframe.”

LGC was advised by CMS Cameron McKenna LLP.